Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

765 ARTÍCULOS , VIENDO DEL 661 AL 675

Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease

Cummings J, Osse AML, Cammann D, Powell J, Chen J.

BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13.

Efficacy of anti-amyloid-ß monoclonal antibody therapy in early Alzheimer's disease: a systematic review and meta-analysis

Dantas JM, Mutarelli A, Navalha DDP, Dagostin CS, Romeiro PHCL, Felix N, Nogueira A, Batista S, Teixeira L, Caramelli P.

Neurol Sci. 2024 Jun;45(6):2461-2469. doi: 10.1007/s10072-023-07194-w. Epub 2023 Nov 17.

A systematic review of reminder and guidance systems for Alzheimer's Disease and Related Dementias patients: context, barriers and facilitators

Peres B, Campos PF.

Disabil Rehabil Assist Technol. 2024 Aug;19(6):2133-2146. doi: 10.1080/17483107.2023.2277821. Epub 2023 Nov 21.

Clarity on the blazing trail: clearing the way for amyloid-removing therapies for Alzheimer's disease

Lian Y, Jia YJ, Wong J, Zhou XF, Song W, Guo J, Masters CL, Wang YJ.

Mol Psychiatry. 2024 Feb;29(2):297-305. doi: 10.1038/s41380-023-02324-4. Epub 2023 Nov 24.

Environmental Toxins and Alzheimer's Disease: a Comprehensive Analysis of Pathogenic Mechanisms and Therapeutic Modulation

Dhapola R, Sharma P, Kumari S, Bhatti JS, HariKrishnaReddy D.

Mol Neurobiol. 2024 Jun;61(6):3657-3677. doi: 10.1007/s12035-023-03805-x. Epub 2023 Nov 25.

Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment

Chaves JCS, Dando SJ, White AR, Oikari LE.

Biochim Biophys Acta Mol Basis Dis. 2024 Feb;1870(2):166967. doi: 10.1016/j.bbadis.2023.166967. Epub 2023 Nov 24.

Targeting synapse function and loss for treatment of neurodegenerative diseases

Dejanovic B, Sheng M, Hanson JE.

Nat Rev Drug Discov. 2024 Jan;23(1):23-42. doi: 10.1038/s41573-023-00823-1. Epub 2023 Nov 27.

Pathogenesis of Depression in Alzheimer's Disease

Zhan Q, Kong F, Shao S, Zhang B, Huang S.

Neurochem Res. 2024 Mar;49(3):548-556. doi: 10.1007/s11064-023-04061-0. Epub 2023 Nov 28.

Radiation Therapy in Alzheimer's Disease: A Systematic Review

Kaul D, Ehret F, Roohani S, Jendrach M, Buthut M, Acker G, Anwar M, Zips D, Heppner F, Prüss H.

Int J Radiat Oncol Biol Phys. 2024 May 1;119(1):23-41. doi: 10.1016/j.ijrobp.2023.11.044. Epub 2023 Nov 30.

Targets, trials and tribulations in Alzheimer therapeutics

Gharat R, Dixit G, Khambete M, Prabhu A.

Eur J Pharmacol. 2024 Jan 5;962:176230. doi: 10.1016/j.ejphar.2023.176230. Epub 2023 Dec 1.

Understanding Glycogen Synthase Kinase-3: A Novel Avenue for Alzheimer's Disease

Sequeira RC, Godad A.

Mol Neurobiol. 2024 Jul;61(7):4203-4221. doi: 10.1007/s12035-023-03839-1. Epub 2023 Dec 8.

Once upon a time, the Amyloid Cascade Hypothesis

Granzotto A, Sensi SL.

Ageing Res Rev. 2024 Jan;93:102161. doi: 10.1016/j.arr.2023.102161. Epub 2023 Dec 6.

Gene therapy: an alternative to treat Alzheimer's disease

Doshi V, Joshi G, Sharma S, Choudhary D.

Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3675-3693. doi: 10.1007/s00210-023-02873-z. Epub 2023 Dec 11.

Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review

Khalifa MKA, Abdel-Sattar SA, Amin OM, Kohaf NA, Zaky HS, Abd El-Fattah MA, Mohammed KHA, Badawi NM, Mansoor I, Eassa HA.

Daru. 2024 Jun;32(1):319-337. doi: 10.1007/s40199-023-00494-8. Epub 2023 Dec 11.

Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review

Vicente-Zurdo D, Rosales-Conrado N, León-González ME.

Talanta. 2024 Mar 1;269:125519. doi: 10.1016/j.talanta.2023.125519. Epub 2023 Dec 7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias